Researchers Identify a Genetic Vulnerability in Candida auris, Opening New Paths for Antifungal Drug Development
A new scientific study has identified a key genetic weakness in Candida auris, a highly drug-resistant fungal pathogen. This report reviews the findings, explains the biological significance of the vulnerability, discusses implications for antifungal drug development, and outlines why this discovery matters for global health systems.
Share